Additional file 2 of Microbial risk score for capturing microbial characteristics, integrating multi-omics data, and predicting disease risk

Additional file 2: Table S1. Number of discovery and validation samples used for MRS evaluation and validation from the GMHI multi-study cohort. Table S2. AUC values for six common alpha diversity indices on the whole community to predict alive and deceased status in the NYULH COVID-19 cohort. Table S3. The identified species for MRSα construction in terms of comparisons among healthy, CA, CC, CD, RA, and nonhealthy based on the discovery samples in the GMHI multi-study cohort. Table S4. Average and standard deviation of relative abundances of the identified species in Healthy, CA, CC, CD, and RA discovery samples from the GMHI multi-study cohort. The identified species are used for MRSα construction in terms of pairwise comparisons of Healthy versus CA, CC, CD, and RA, respectively. Table S5. Average and standard deviation of relative abundances of the identified species in Healthy, CA, CC, CD, and RA validation samples from the GMHI multi-study cohort. The identified species are used for MRSα construction in terms of pairwise comparisons of Healthy versus CA, CC, CD, and RA, respectively. Table S6. Factors used for metagenomic, metatranscriptomic and host transcriptomic risk scores in the NYULH COVID-19 cohort.